analyzeportfolio
OTC · Healthcare

Charlie's Holdings, Inc. (CHUC)

As-reported financials and SEC filings for Charlie's Holdings, Inc. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About Charlie's Holdings, Inc.

Charlie's Holdings, Inc. operates in the cybersecurity sector, focusing on incident response and recovery planning to address cybersecurity incidents. The company maintains risk processes for informing its board committee responsible for oversight. It serves clients requiring cybersecurity risk management and recovery solutions.

Snapshot

Revenue
$20.9M
Revenue growth (YoY)
169.4%
Net income
$4.5M
Diluted EPS
$0.02
Gross margin
27.0%
Operating margin
-10.4%
Net margin
21.5%
FCF margin
-27.7%
ROE
131.4%
net income / fiscal-year-end equity
P/E
11.0×
trailing when available, otherwise FY EPS
Market cap
$61.7M
Long-term debt / equity
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Charlie's Holdings

  • Revenue grew 169.4% to $21M in FY2025, after a 52.2% decline the year before.
  • Operating margin is now a 10.4% loss in FY2025, from 2.6% in FY2021.
  • Most recent quarter Q2 FY2026: revenue $4M, up 115.9% from Q2 FY2025.
  • Free cash flow was negative $6M in FY2025.
  • Net income turned positive at $4M in FY2025, from a $4M loss in FY2024.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Charlie's Holdings’s fundamentals sit among the 558 Healthcare companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin27.0%
8th percentile of 282
Operating margin-10.4%
35th percentile of 399
Net margin21.5%
88th percentile of 418
FCF margin-27.7%
15th percentile of 372
Revenue growth (YoY)+169.4%
93rd percentile of 538
ROE131.4%
99th percentile of 473
P/E11.0×
17th percentile of 201
Short interest1.00d
1st percentile of 557

Charlie's Holdings’s return on equity of 131.4% ranks in the 99th percentile of the 473 Healthcare companies reporting it. Charlie's Holdings’s revenue growth of +169.4% ranks in the 93rd percentile of the 538 Healthcare companies reporting it. Charlie's Holdings’s gross margin of 27.0% ranks in the 8th percentile of the 282 Healthcare companies reporting it.

No reported insider transactions (codes P/S) in the last 90 days. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
18.7K
settled 2026-08-14
Change vs prior
+100.0%
vs previous settlement
Days to cover
1.00
at avg daily volume
Avg daily volume
87.4K
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-1418.7K+100.0%1.00
2026-06-3019.7K-45.0%1.00
2026-06-1535.8K+51.9%1.00
2026-05-2923.6K+182.9%1.00
2026-05-158.3K+36.8%1.00
2026-04-306.1K+2281.3%1.00
2026-04-15256+63.1%1.00
2026-03-31157-98.4%1.00

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$20.9M$7.8M$16.3M$26.4M$21.5M
Gross profit$5.7M$2.9M
Operating income$-2.2M$-3.3M$-2.2M$-1.8M$565,000
Net income$4.5M$-4.2M$-2.1M$-1.6M$4.8M
Diluted EPS$0.02$-0.02$-0.01$-0.01$0.01

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

 FY2025FY2024FY2023FY2022FY2021
Cash and equivalents
Current assets$10.8M$3.7M$5.1M$5.8M$8.0M
Total assets$11.6M$3.9M$5.8M$7.1M$9.2M
Current liabilities$7.6M$5.6M$4.8M$4.8M$5.5M
Long-term debt$2.2M$2.5M$1.4M$150,000
Total liabilities$8.1M$5.7M$5.9M$5.4M$6.1M
Total equity$3.4M$-1.8M$-107,000$1.7M$3.1M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$-5.8M$-1.6M$-783,000$-1.7M$-1.3M
Capital expenditure$23,000$0$0$189,000$110,000
Free cash flow$-5.8M$-1.6M$-783,000$-1.9M$-1.5M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$3.8M115.9%$-1.7M
Q1 FY2026$4.8M204.4%$-1.1M
Q4 FY2025$9.0M757.9%$131,000$0.00
Q3 FY2025$7.1M336.2%$624,000$0.00
Q2 FY2025$1.8M-13.8%$5.0M$0.00
Q1 FY2025$1.6M-48.3%$-1.2M$0.00
Q4 FY2024$1.0M-81.1%$-1.1M$-0.00
Q3 FY2024$1.6M-40.0%$-1.0M$0.00

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeOTC
SectorHealthcare
SIC industryMedicinal Chemicals & Botanical Products
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2001
SEC CIK1134765

Selected SEC filings

10-K2026-04-01
View on EDGAR →
10-K2025-05-29
View on EDGAR →
10-Q2026-08-17
View on EDGAR →
10-Q2026-05-20
View on EDGAR →
10-Q2025-11-19
View on EDGAR →
10-Q2025-08-21
View on EDGAR →
8-K2026-08-04
View on EDGAR →
8-K2026-06-05
View on EDGAR →

Largest Healthcare peers

All Healthcare companies →

Monitor CHUC

Get an alert when Charlie's Holdings files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor CHUC free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.